Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Total Current Liabilities (2020 - 2025)

Beauty Health (SKIN) has disclosed Total Current Liabilities for 6 consecutive years, with $59.4 million as the latest value for Q2 2025.

  • On a quarterly basis, Total Current Liabilities fell 21.19% to $59.4 million in Q2 2025 year-over-year; TTM through Jun 2025 was $59.4 million, a 21.19% decrease, with the full-year FY2024 number at $68.2 million, down 40.74% from a year prior.
  • Total Current Liabilities was $59.4 million for Q2 2025 at Beauty Health, down from $68.2 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $115.0 million in Q4 2023 to a low of $813471.0 in Q1 2021.
  • A 5-year average of $66.2 million and a median of $71.7 million in 2022 define the central range for Total Current Liabilities.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 60.37% in 2023, then tumbled 40.74% in 2024.
  • Beauty Health's Total Current Liabilities stood at $39.5 million in 2021, then skyrocketed by 81.59% to $71.7 million in 2022, then surged by 60.37% to $115.0 million in 2023, then crashed by 40.74% to $68.2 million in 2024, then fell by 12.78% to $59.4 million in 2025.
  • Per Business Quant, the three most recent readings for SKIN's Total Current Liabilities are $59.4 million (Q2 2025), $68.2 million (Q4 2024), and $75.4 million (Q2 2024).